Skip to main content
Equibles

JANE STREET GROUP, LLC

Position in CDXS — Codexis, Inc.

CIK 1595888 NEW YORK, NY
Back to CDXS Full portfolio

Position in CDXS

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$273,041
-$1,226,500 QoQ
Shares Held
120,815
-86.9% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#47
of 148 holders
Holding Since
Dec 2020
13 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CDXS Over Time

Shares Held

Position Value (USD)

Derivatives in CDXS

reported options exposure · as of Mar 31, 2022
CallValue
$550,554
CallShares
26,700
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JANE STREET GROUP, LLC holds $1,372,861,470 across 292 Biotechnology names. CDXS ranks #155 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BBIO
BridgeBio Pharma, Inc.
 2,934,193 $218,538,693
2 MDGL
Madrigal Pharmaceuticals, Inc.
 191,541 $102,847,939
3 AXSM
Axsome Therapeutics, Inc.
 403,995 $98,885,855
4 TGTX
Tg Therapeutics, Inc.
 1,752,646 $96,290,370
5 EXEL
Exelixis, Inc.
 1,402,438 $76,306,651
6 QURE
uniQure N.V.
 1,610,483 $74,178,846
7 HALO
Halozyme Therapeutics, Inc.
 694,684 $54,372,915
8 TVTX
Travere Therapeutics, Inc.
 938,699 $53,327,489

All Filings in CDXS

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $273,041 120,815
2026-03-31 $1,499,541 919,964
2025-12-31 $488,885 299,930
2025-09-30 $122,627 50,258
2024-09-30 $177,764 57,716
2024-06-30 $200,606 64,712
2024-03-31 $189,960 54,430
2023-12-31 $159,633 52,339
2023-09-30 $51,183 27,081
2023-03-31 $50,429 12,181
2022-09-30 $63,090 10,411
2022-03-31 $550,554 26,700
2020-12-31 $973,072 44,575